Google’s parent company funds start-up to 'edit genes to protect against heart disease'

Alphabet is funneling funds to Verve Therapeutics, a start-up that is trying to develop a single injection containing CRISPR to gene-edit protective DNA into people at risk for heart disease.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news